These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9289710)

  • 1. [Examination of interleukin levels and growth factor from blood platelets in leukemia].
    Kiersnowska-Rogowska B; Rogowski F; Petelski T; Citko A; Jaroszewicz E; Bielawiec M
    Pol Tyg Lek; 1996 May; 51(19-22):281-2, 288. PubMed ID: 9289710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon production in myelo- and lymphoproliferative diseases. I. Spontaneous interferon production in acute and chronic leukaemias.
    Szabó B; Tóth FD; Kiss J; Váczi L; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(3):295-300. PubMed ID: 2465655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines in acute myeloid leukemia].
    Kiersnowska-Rogowska B; Rogowski F; Petelski T; Sawicka-Powierza J; Parfieńczyk A; Bodzenta-Lukaszyk A; Citko A; Jaroszewicz E
    Pol Merkur Lekarski; 1998 May; 4(23):259-61. PubMed ID: 9825657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical manifestations of chronic granulocytic leukemia.
    Spiers AS
    Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue factor (TF) and inhibitor (TFPI) concentrations in patients with urinary tract tumors and haematological malignancies].
    Radziwon P; Schenk JF; Mazgajska K; Boczkowska-Radziwon B; Galar M; Kłoczko J; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):308-11. PubMed ID: 12557438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Feb; 16(92):157-61. PubMed ID: 15176301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ferritin in myeloproliferative diseases].
    Aulbert E; Fromm H
    Med Klin (Munich); 1990 Mar; 85(3):125-31. PubMed ID: 2336046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
    Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia.
    Catovsky D; O'Brien M; Cherchi M; Benavides I
    Boll Ist Sieroter Milan; 1978 Jul; 57(3):344-54. PubMed ID: 282904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and adhesion molecule concentrations in blood of patients with B-cell chronic lymphocytic leukaemia with regard to disease progression.
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Rocz Akad Med Bialymst; 2003; 48():90-4. PubMed ID: 14737950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
    Chai SK; Nichols GL; Rothman P
    J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function in acute leukemias.
    Naresh KN; Sivasankaran P; Veliath AJ
    J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cryopreservation on human leukaemic clonogenic cells (CFU-L).
    Elstner E; Wächter M; Blau IW
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):313-7. PubMed ID: 1697835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia.
    Gora-Tybor J; Blonski JZ; Robak T
    Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.